CMS released its proposed 2027 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center rule last week. It proposes a modest payment bump alongside several deep cuts. Below are ...

Federal spending on the Medicare Advantage quality bonus program will rise to $13.4 billion in 2026 from $12.7 billion in 2025, according to a new report from KFF. This is four times higher than in ...

It’s well known that private equity has drastically increased its presence in the healthcare industry, acquiring hospitals, physician practices and other providers. These acquisitions have received ...

Anthropic is rolling out Claude Science, an AI workbench for pharma researchers. The buzzy AI startup says this new product goes beyond assisting scientists to actually doing their work. “Claude can ...

Many blood cancers can be treated with a potentially curative stem cell transplant, but this procedure introduces a serious complication risk that can become deadly. A new type of cell therapy gives ...

Regulatory pressure is mounting on Amgen’s inflammatory disorder drug, Tavneos, with the European Medicines Agency (EMA) recommending revocation of the product’s approval in its territory. The move ...

This roundup is published monthly. It is meant to highlight some of healthcare’s recent hiring news and is not intended to be comprehensive. If you have news about an executive appointment, ...

The flux around CMS Star Ratings continues. Lawsuits from health insurers over Medicare Advantage Star Ratings have increased in recent years, though with varying results. Some plans like SCAN and ...

Notebook page with text MEDICARE, on a table with a stethoscope and pen, medical concept. A group of Democratic senators introduced a new bill on Thursday that would create a $5,000 cap on ...

If you have interacted in the past few years with a medical chatbot, you probably walked away feeling like it was helpful for simple tasks and frustrating for anything even slightly complex. Reset a ...

A Viridian Therapeutics drug for thyroid eye disease now has FDA approval, making it just the second therapy for this inflammatory disorder and one offering key competitive advantages over the Amgen ...

Upside, a housing stability platform partnering with health insurers, announced Thursday that it raised $20 million in Series A funding. The company’s AI-powered platform helps payers and employers ...